NeoCore Technology , Ltd. (4131.TWO) has a profit margin of -12.51%, below the Healthcare sector average of 9.71%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest profit margin for 4131.TWO is -12.51% as of June 2026. That compares with -11.74% in the prior-year period — down 6.6% year over year. That is below the Healthcare sector average of 9.71%. Investors often review this figure alongside NeoCore Technology , Ltd.'s historical trend and sector peers before judging valuation or financial health.
Over the past year, 4131.TWO's profit margin moved from -11.74% to -12.51% — a 6.6% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NeoCore Technology , Ltd.'s valuation or profitability profile.
Against Healthcare companies, 4131.TWO currently prints -12.51% for profit margin, while the sector average sits near 9.71%. That is roughly 228.9% below the sector mean. Large gaps often invite a closer look at NeoCore Technology , Ltd.'s growth, margins, and balance sheet.
Profit Margin shows how effectively NeoCore Technology , Ltd. converts resources into returns. At -12.51%, 4131.TWO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -11.74% in the prior-year period — down 6.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting 4131.TWO's profit margin (-12.51%), review year-over-year change from -11.74%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.